Many infectious diseases affecting the developing world are potentially treatable in the longer term. However, economic disincentives have resulted in underinvestment in medical research for new vaccines and medicines targeted at these diseases.
A fatal imbalance exists in the investment in new drugs for neglected diseases, such as sleeping sickness and leishmaniasis, versus diseases prevalent in wealthy countries. From 1975 to 2004, of the 1,556 new drugs marketed only 21 just over one percent were for infectious tropical diseases and tuberculosis, in spite of the huge need.
The illnesses of invisible people usually stay invisible. This statement is reflective of the limited attempts to develop new treatment regimens for neglected diseases. Most of these diseases are preventable or curable, but often strike poor and marginalized people living in remote rural areas.
At a time when progress toward the UN Millennium Development Goals is faltering, access to healthcare in general and reproductive healthcare in particular is becoming more of a challenge than ever.
Partnership, a good feelings evocative concept, is one of the trendiest key words in the international development jet set today. Repeatedly, declarations and commitments summarising international events conclude launching new global partnerships to solve the problems they have been addressing.
Pakistan currently principally uses three modes of financing health taxation, out of pocket payments and donor contributions of which the latter is the least significant in terms of size. The government spends 0.6 of its GDP and 11.6% of its development budget on health.
Numerous international funds have been set up in recent times to address global health challenges such as HIV, TB and malaria, in an effort to provide sustainable funding for selected diseases affecting billions of people in the poorer regions of the world.
As part of the broad topic on how to provide equal access to health, this symposium discussed how tools such as telemedicine can increase access to medical information and contribute to the reduction of the global digital gap.
The emergence of new infectious diseases such as Severe Acute Respiratory Syndrome (SARS) and avian influenza A (H5N1); and the re-emergence of others such as cholera and yellow fever combined with the increased speed and volume of international travel and trade have alerted countries to the ease with which infectious diseases can cross national borders […]
It is a truism that health policy as well as the teaching and practice of the health sciences ought to be guided by evidence. The collection and validation of this evidence has to depend on methodologically and ethically acceptable standards. Whilst there is some agreement that issues related to methodology have been fairly well addressed […]